Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of GC3106 Influenza Vaccine in Healthy Adults
NCT02658409Phase 3Unknown
- Sponsor
- GC Biopharma
- Start
- Nov 2015
- Primary completion
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GC3106 in influenza, sponsored by GC Biopharma. Status: unknown.
02
Drugs
GC3106
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02658409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02658409.